International Journal of Hyperthermia · 2021 · 21 citations · 23 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyGastrointestinal Radiation OncologyAdjuvant ChemotherapyNeoadjuvant ChemotherapyNeoadjuvant PharmacotherapyNeoadjuvant TherapyRadiation TherapyResponse AssessmentColorectal Cancer Neoadjuvant TherapyHyperthermiaNeoadjuvant Clinical TrialsNeoadjuvant Radiation TherapyNeoadjuvant Therapy TrialsRectal Cancer Neoadjuvant TherapyRectal Cancer RadiotherapyTumor Response Evaluation
PURPOSE: Modulated electro-hyperthermia (mEHT) may enhance the tumor response, although the effectiveness of combined neoadjuvant therapy remains unclear. Therefore, we investigated the role of mEHT with neoadjuvant therapy for locally advanced rectal cancer. MATERIALS AND METHODS: Clinical data were analyzed for 120 patients who received neoadjuvant treatment for locally advanced rectal cancer (T3/4 or N+, M0) from May 2012 to December 2017. Capecitabine or 5-fluorouracil was administered along with radiotherapy. Patients were categorized into mEHT group (62 patients) and non-mEHT group (58 patients) depending on whether mEHT was added. Surgery was performed 6-8 weeks after the end of radiotherapy. RESULTS: = .054). CONCLUSION: The overall mEHT group had a comparable response and survival using less radiation dosing compared with standard care; the subgroup with large tumors showed improved efficacy for tumor regression after mEHT.
23
Eric Van Cutsem, Paulo M. Hoff, Peter Harper et al. · British Journal of Cancer · 2004 · 398 citations · Full text
Medicine, Oncology, Pharmacology +14